Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,541,417
+$1,257,479 QoQ
Shares Held
208,687
+35.4% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 279 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. AUPH ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in AUPH
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,541,417 | 208,687 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,283,938 | 154,112 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,394,555 | 87,433 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,161,021 | 105,070 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,005,760 | 118,744 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $981,482 | 122,075 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,294,123 | 144,112 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,045,924 | 142,691 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $820,342 | 143,668 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $706,685 | 141,055 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,300,752 | 144,689 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,048,467 | 134,938 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,223,812 | 126,427 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,388,752 | 126,711 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $356,757 | 82,583 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $665,150 | 88,451 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $868,983 | 86,466 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $405,456 | 32,751 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $260,969 | 11,411 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $323,739 | 14,629 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $232,903 | 17,971 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||